<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>佰傲谷BioValley | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-20T13:24:42+08:00</updated>
  <subtitle>佰傲谷致力于打造一个垂直于生物制品领域的第三方平台。为生物制药企业提供品牌推广、技术咨询、项目交易、企业合作、人才培养等服务。为生物制药行业从业人员提供沟通交流、会议培训、工作求职、个人展示平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>靶点药讯40|纵览全球药物靶点动态</title>
    <updated>2020-12-20T12:12:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/r84AU8PQiUqt5hg_0iO47g</id>
    <link href="https://mp.weixin.qq.com/s/r84AU8PQiUqt5hg_0iO47g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 Think Big 十佳入选项目专访 | 朔望医药：用基因治疗守护人类视觉健康</title>
    <updated>2020-12-19T10:19:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/GneIqva9_VBjsx3uUyoBig</id>
    <link href="https://mp.weixin.qq.com/s/GneIqva9_VBjsx3uUyoBig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA毫无悬念批准第二款新冠疫苗，定价最低25美元</title>
    <updated>2020-12-19T10:19:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/Pz--d0OH23O_NDMGXeDdaQ</id>
    <link href="https://mp.weixin.qq.com/s/Pz--d0OH23O_NDMGXeDdaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>葛兰素史克（GSK）8亿美元押注全新免疫检查点PVRIG</title>
    <updated>2020-12-18T12:55:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/beiGw0jC-3vt3cAKA0R61Q</id>
    <link href="https://mp.weixin.qq.com/s/beiGw0jC-3vt3cAKA0R61Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>除了Margenza，还有哪些HER2乳腺癌辅助治疗方案？</title>
    <updated>2020-12-18T12:55:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/MSOxVb4ERzqCAboUDVPj0w</id>
    <link href="https://mp.weixin.qq.com/s/MSOxVb4ERzqCAboUDVPj0w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年底跳槽季，什么岗位能洞悉生物医药行业局势？</title>
    <updated>2020-12-18T12:55:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/_HiuYRD54dbU6mbJyy-4Kw</id>
    <link href="https://mp.weixin.qq.com/s/_HiuYRD54dbU6mbJyy-4Kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>佰傲谷分享 | CDE官方指导文件获取！</title>
    <updated>2020-12-18T12:55:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/BX12Hh2mSy15DFQoMdyMNQ</id>
    <link href="https://mp.weixin.qq.com/s/BX12Hh2mSy15DFQoMdyMNQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关于新冠疫苗，我们应该期待什么？</title>
    <updated>2020-12-17T12:29:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/udg4YlbINYgd8gN59LkGRA</id>
    <link href="https://mp.weixin.qq.com/s/udg4YlbINYgd8gN59LkGRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>非小细胞肺癌靶向新药--KRAS G12C抑制剂</title>
    <updated>2020-12-17T12:29:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/wVGRRnPdAbSShZEXrGNjpA</id>
    <link href="https://mp.weixin.qq.com/s/wVGRRnPdAbSShZEXrGNjpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>佰傲谷发布 | 股价大涨9%，再破5000亿！恒瑞PD-1四个适应症全进医保！</title>
    <updated>2020-12-17T12:29:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/_UKIvZ__FOpppcAdEV1a2w</id>
    <link href="https://mp.weixin.qq.com/s/_UKIvZ__FOpppcAdEV1a2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>佰傲谷分享 | CDE官方指导文件获取！</title>
    <updated>2020-12-17T12:29:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/LxmzIoMbilLYyCR-CWn1PA</id>
    <link href="https://mp.weixin.qq.com/s/LxmzIoMbilLYyCR-CWn1PA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>如果中国生物医药也被“卡脖子”，哪里会成为软肋？</title>
    <updated>2020-12-16T16:45:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/KVSYUAAtvPNXPfPs9zt3Yw</id>
    <link href="https://mp.weixin.qq.com/s/KVSYUAAtvPNXPfPs9zt3Yw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>鸿运华宁郑州生产基地启动，为单抗药物上市及国际化做准备</title>
    <updated>2020-12-16T16:45:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/XXJaBIJaBBKMcXG_12lR0g</id>
    <link href="https://mp.weixin.qq.com/s/XXJaBIJaBBKMcXG_12lR0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>发夹和剪刀--提供非基因编辑的同种异体CAR T细胞疗法</title>
    <updated>2020-12-16T16:45:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/TRJaGBc75AzEfGsGGzMTyw</id>
    <link href="https://mp.weixin.qq.com/s/TRJaGBc75AzEfGsGGzMTyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先天淋巴细胞（ILCs）</title>
    <updated>2020-12-16T16:45:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/kScylIpgMXrX3p-LOznpJA</id>
    <link href="https://mp.weixin.qq.com/s/kScylIpgMXrX3p-LOznpJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>佰傲谷分享 | CDE官方指导文件获取！</title>
    <updated>2020-12-16T16:45:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/NQDDxR0vrInz3gYjzS90JA</id>
    <link href="https://mp.weixin.qq.com/s/NQDDxR0vrInz3gYjzS90JA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先跌为敬？集采中标是股价滑铁卢还是买点？</title>
    <updated>2020-12-15T12:59:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/OCq9AoiH1TZucMTh8tztfw</id>
    <link href="https://mp.weixin.qq.com/s/OCq9AoiH1TZucMTh8tztfw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【依科赛学院】血清知识快问快答~</title>
    <updated>2020-12-15T12:59:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/rfQhwX41IAhe0CY4RvdThA</id>
    <link href="https://mp.weixin.qq.com/s/rfQhwX41IAhe0CY4RvdThA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>歌礼子公司NASH药物获FDA快速通道资格认定</title>
    <updated>2020-12-15T12:59:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/lRGWaBcAeBU1KsELw-VkIQ</id>
    <link href="https://mp.weixin.qq.com/s/lRGWaBcAeBU1KsELw-VkIQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康390亿收购Alexion的背后，靶向补体药物开发前景如何？</title>
    <updated>2020-12-14T12:12:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/-uh02RtE0tdQHmwRe0mToQ</id>
    <link href="https://mp.weixin.qq.com/s/-uh02RtE0tdQHmwRe0mToQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>